TITLE:
Recombinant Human Keratinocyte Growth Factor in Unrelated and Related Transplants

CONDITION:
Graft Versus Host Disease

INTERVENTION:
recombinant human keratinocyte growth factor

SUMMARY:

      This is a single arm dose escalation study of recombinant human keratinocyte growth factor
      given to patients undergoing allogeneic bone marrow transplantation who are at high risk for
      graft versus host disease (GVHD).
    

DETAILED DESCRIPTION:

      Completion date provided represents the completion date of the grant per OOPD records
    

ELIGIBILITY:
Gender: All
Age: 3 Years to 65 Years
Criteria:

        Eligible for full intensity bone marrow transplant (BMT) conditioning but who lack a 6/6
        HLA idential sibling donor
      
